← Back

Wire · operational-macro

Biostream Urine Test Declared FDA Breakthrough Device

Published

20 November 2026

Topic

operational-macro

◆ Sectors

Diagnostics

◆ Geography

United States

◆ Source

Read at genomeweb.com →

◆ Verified

Fusion42 · 20 November 2026 · Fusion42 review

The FDA has granted breakthrough device designation to Biostream's investigational urine test for idiopathic normal pressure hydrocephalus, recognising its potential to address a significant unmet medical need.

This Wire brief sits within Fusion42's coverage of Diagnostics, and 2 sources have reported it.

◆ ◆ The Wire takeaway

The FDA's nod opens a faster route to market for you if you're developing diagnostics for neurological disorders. This status can boost investor and partner interest immediately.

◆ Coverage

2 sources · 20 Nov 2026

◆ Related on Wire

◆ Topics

Diagnosticsfdabreakthrough-devicediagnosticsurine-testhydrocephalus